Alendronate treatment of established primary osteoporosis in men: Results of a 2-year prospective study

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 11, 2001, Pages 5252-5255

  Ringe, J D ^a   Faber, H ^a   Dorst, A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DOSS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CALCIUM INTAKE; CLINICAL TRIAL; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; FRACTURE; HIP FRACTURE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; VERTEBRA FRACTURE;

EID: 0035187341     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.11.7988     Document Type: Article

References (33)

1. The economic and human costs of osteoporotic fracture
2. Osteoporosis in men
3. Hip fractures in the elderly: A world-wide projection
4. The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study
5. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism
6. Effects of testosterone replacement in hypogonadal men
7. Effect of testosterone treatment on bone mineral density in men over 65 years of age
8. The prevention and therapy of osteoporosis in men
9. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate
10. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
11. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
12. Prevention of nonvertebral fractures by alendronate: A meta-analysis
13. Alendronate for the treatment of osteoporosis in men
14. Progressive loss of bone in the femoral neck in elderly people: Longitudinal findings from the Dubbo osteoporosis epidemiology study
15. Osteoporosis in men
16. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
17. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
18. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis
19. Androgen supplementation in eugonadal men with osteoporosis: Effects of 6 months of treatment on bone mineral density and cardiovascular risk factors
20. Osteoporosis in men
21. Pre-existing fractures and bone mass predict vertebral fracture incidence in women
22. Bone density at various sites for prediction of hip fractures
23. Bone mineral density predicts non-spine fractures in very elderly women
24. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
25. Prediction of osteoporotic fractures by postural instability and bone density
26. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: The EVOS study
27. Bone density and fracture risk in men
28. Hip fracture prediction in elderly men and women: Validation in the Rotterdam study
29. Risk factors for hip fracture in white men: The NHANES I epidemiologic follow-up study
30. Risk factors for hip fracture in men from southern Europe: The MEDOS study
31. Do men and women fracture bones at similar bone densities?
32. Effects of alendronate on bone density in men with primary and secondary osteoporosis
33. Osteoporosis in men: Clinical assessment of 400 patients and 205 controls by risk factor analysis, densitometry, and x-ray findings